TLRY

Tilray Brands, Inc. TLRY

NasdaqSmall CapHealthcare

13F Pro quality score

Rank #2,291 of 2,925

Why it scores 36Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$257.15M

Quarter to Aug 31

Net income

$-43.14M

Quarter to Aug 31

Operating margin

-9.3%

Quarter to Aug 31

Top Institutional Holders

as of Q2 2026
$124.25M total
Graham Capital Management, L.P.
$46.99M-21.2%
DeepCurrents Investment Group LLC
$13.13M-47.9%
Toroso Investments, LLC
$11.22M-2.5%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$4.59M+88.4%
MORGAN STANLEY
$4.47M+55.2%
CITADEL ADVISORS LLC
$3.90M+6142.1%
Point72 Asset Management, L.P.
$2.91MNew
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.
$2.90M+32.9%
D. E. Shaw & Co., Inc.
$2.67M-4.0%
AQR CAPITAL MANAGEMENT LLC
$2.30M+14.5%
BlackRock, Inc.
$2.07M+9.2%
UBS Group AG
$2.04M-30.4%
LAZARD ASSET MANAGEMENT LLC
$1.77MNew
STATE STREET CORP
$1.72M+54.9%
VANGUARD PORTFOLIO MANAGEMENT LLC
$1.57M-0.1%
STIFEL FINANCIAL CORP
$1.31MNew
XTX Topco Ltd
$1.10MNew
Swiss National Bank
$1.05M+1.4%
GOLDMAN SACHS GROUP INC
$935.1K+31.0%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME
$934.9K+6.1%
Headlands Technologies LLC
$721.4K-8.2%
TWO SIGMA INVESTMENTS, LP
$610.1K-26.5%
JANE STREET GROUP, LLC
$551.6K-67.1%
NORTHERN TRUST CORP
$496.9K-0.1%
SIG North Trading, ULC
$450.8K+39.9%
See all 242 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q1 2027
EDGAR

Net Income

Q1 2027
EDGAR

EPS (Diluted)

Q1 2027
EDGAR

Operating Margin

Q1 2027
EDGAR

ROIC

Q1 2027
EDGAR

Debt/Equity

Q1 2027
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/TLRY

Earnings Per Share

13fpro.ai/company/TLRY

Loading ratio trend…

TLRY key financials by period

Reported revenue, net income and operating margin by fiscal year, from Tilray Brands, Inc.'s annual filings on SEC EDGAR.

Tilray Brands, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2026$915.5M$-121.4M-6.9%
FY 2025$821.3M$-2.2B—
FY 2024$788.9M$-245.0M-22.1%
FY 2023$627.1M$-1.5B—
FY 2022$628.4M$-476.8M-97.1%
FY 2021$513.1M$-367.4M-25.8%
Source: TLRY filings on SEC EDGAR →

Companies similar to TLRY

Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.

TLRY insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

Congress trading in TLRY

5 transactions in TLRY reported by 1 member of Congress under the STOCK Act, most recent trade Apr 18, 2022. Reported transactions, not recommendations.

All Congress stock trades →

About Tilray Brands, Inc. (TLRY): stock profile, AI score and financials

Tilray Brands, Inc. (TLRY) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores TLRY at 35.6/100 on a composite quality score built from its SEC filings, placing it at rank #2,291 of 2,925 stocks — the bottom half of the AI-ranked universe. Areas of concern include institutional flow (0.3) and free cash flow (16.5), which score below median versus the broader universe. Shareholder dilution risk is elevated at 24.1/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2027), Tilray Brands, Inc. reports quarterly revenue of $257.1M, net income of $-43.1M, an operating margin of -9.3%. TLRY trades on the Nasdaq exchange and files with the SEC under CIK 1731348. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TLRY daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Tilray Brands, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1731348 →